Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2053-2020

Philips HeartStart XL Defibrillator/Monitor (Model number M4735A) - Product Usage: is for use in the hospital by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac life support, or defibrillation. It must be used by or on the order of a physician.

Publicado el 27 de mayo de 2020 · Inicio del retiro: 13 de abril de 2020

Resumen

FDA registra el retiro Z-2053-2020 de dispositivos médicos de Clase II, publicado el 27 de mayo de 2020 e iniciado el 13 de abril de 2020. Empresa responsable: Philips North America, LLC; Estado: Finalizado; Cantidad reportada: 94,034 units; Lote: All units. Product has been discontinued. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

The rotary therapy selector switch may fail, resulting in unexpected device behavior including: 1) The device may not turn on; 2) The device may not perform the selected function;3) The device may deliver a shock with an energy level different than the setting selected by the user. In any of these scenarios, appropriate therapy delivery may be delayed.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Philips North America, LLC
Distribuidor
Worldwide distribution - US Nationwide distribution.
Lote
All units. Product has been discontinued.
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Philips HeartStart XL Defibrillator/Monitor (Model number M4735A) - Product Usage: is for use in the hospital by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac life support, or defibrillation. It must be used by or on the order of a physician. fue retirado del mercado?

Sí. FDA publicó el retiro Z-2053-2020 el 27 de mayo de 2020. Peligro reportado: The rotary therapy selector switch may fail, resulting in unexpected device behavior including: 1) The device may not turn on; 2) The device may not perform the selected function;3) The device may deliver a shock with an energy level different than the setting selected by the user. In any of these scenarios, appropriate therapy delivery may be delayed.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter